Five Factor Model Treatment for Borderline Personality Disorder
- Conditions
- Borderline Personality Disorder
- Interventions
- Behavioral: Personality-Based Cognitive Behavioral Therapy
- Registration Number
- NCT04587518
- Lead Sponsor
- Shannon E. Sauer-Zavala
- Brief Summary
The primary purpose of this study is to explore acceptability, feasibility, and preliminary efficacy of a novel cognitive-behavioral treatment for borderline personality disorder (BPD). Extant treatments for this condition are intensive, long-term (usually at least one year), and have, understandably, focused on targeting the life-threatening and therapy-interrupting behaviors that often characterize this disorder. BPD, however, is a heterogeneous disorder with diagnostic criteria that can be combined to create over 300 unique symptom presentations (Ellis, Abrams, \& Abrams, 2008); to date, no treatments have been explicitly designed with lower risk presentations of BPD in mind. This is unfortunate, as there is evidence to suggest that the majority of individuals with BPD do not demonstrate the recurrent life-threatening behaviors that warrant intensive, long-term care (Trull, Useda, Conforti, \& Doan, 1997; Zimmerman \& Coryell, 1989). Additionally, various studies have shown that the difficulties experienced by individuals with BPD can be understood as manifestations of maladaptive variants of personality traits (e.g., Mullins-Sweatt et al., 2012). Specifically, individuals with BPD demonstrate high levels of neuroticism, and low levels of agreeableness (antagonism) and conscientiousness (disinhibition); these traits may not be universally present across all individuals with BPD, perhaps underscoring the heterogeneity in presentations of this condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 40
-diagnosis of borderline personality disorder (BPD)
- diagnosed psychological conditions that would be better addressed by alternative treatments
- previously received more than 5 sessions of cognitive behavioral therapy in the past 5 years
- concurrent psychotherapy
- medication instability
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Immediate Treatment Personality-Based Cognitive Behavioral Therapy Participants in this group will receive the intervention immediately. Waitlist/Delayed Treatment Personality-Based Cognitive Behavioral Therapy Participants in this group will receive the intervention after an 18-week wait.
- Primary Outcome Measures
Name Time Method Change in clinician-rated borderline personality disorder symptoms 44 weeks (baseline, post-treatment/waitlist, 6 month follow-up) Change in borderline personality disorder symptoms will be measured using Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) - clinician-rated version. Scores range from 0-36; higher scores indicate greater severity of borderline personality disorder symptoms
Change in clinician-rated clinical severity 44 weeks (baseline, post-treatment/waitlist, 6 month follow-up) Clinical severity will be measured using the Diagnostic Interview for Anxiety, Mood, and Obsessive Compulsive and Related Neuropsychiatric Disorders (DIAMOND) dimensional clinician ratings. Scores range from 1-7; higher scores indicate greater severity.
Change in Anxiety Symptoms 12 weeks (baseline, week 1, week, 2, week, 3.....week 12) Anxiety symptoms will be measured using the Overall Anxiety Severity and Interference Scale (OASIS). This is a self-report measure in which scores range from 0-20; higher scores indicate more severe anxiety symptoms.
Change in patient-reported borderline personality disorder symptoms 18 weeks (week 1[baseline for immediate treatment condition, post-waitlist for delayed treatment condition], week, 2, week 3, week, 4.....week 18) Change in borderline personality disorder symptoms will be measured using Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD) - self-report version. Scores range from 0-36; higher scores indicate greater severity of borderline personality disorder symptoms
Change in Depressive Symptoms 12 weeks (baseline, week 1, week, 2, week, 3.....week 12) Depressive symptoms will be measured using the Overall Depression Severity and Interference Scale (ODSIS). This is a self-report measure in which scores range from 0-20; higher scores indicate more severe anxiety symptoms.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Kentucky
🇺🇸Lexington, Kentucky, United States